AbinoNutra(R) Unveils Advanced '5-in-1' Longevity Dietary Supplement Featuring FDA-GRAS Recognized Dr.Ergo(R) L-Ergothioneine

July 25, 2025 11:00 AM

Gotvoom, Inc., in partnership with biotech innovator Abinopharm, Inc., announces the launch of the enhanced AbinoNutra® NAD⁺ Capsule - a next-generation supplement combining science-backed ingredients to support healthy aging, including the breakthrough Dr.Ergo® L-Ergothioneine.Clinically Proven Benefits for Skin and CognitionRecent human studies show that 25-30 mg/day of Dr.Ergo® improves skin brightness, elasticity, and moisture while reducing...

Read more

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1

July 25, 2025 8:45 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization for an updated formulation of the COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older. Following the CHMP's...

Read more

Wellgistics Health Converts $8.1M Debt to Equity

July 25, 2025 7:45 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that its Board of Directors has approved an $8.1 million debt-to-equity conversion.Led by CEO Brian Norton and former minority partners of Wellgistics, LLC, which was acquired by Wellgistics Health in 2024, the transaction strengthens...

Read more

Primus Sounds Alarm on Chronic Venous Insufficiency as President Trump's Diagnosis Sparks National Focus

July 24, 2025 7:25 PM

Following reports of President Donald J. Trump's diagnosis with Chronic Venous Insufficiency (CVI), Primus Pharmaceuticals, Inc. strongly calls on healthcare providers to intensify efforts to diagnose and treat this silent epidemic affecting 25-30 million Americans because only less than Leg swelling, heaviness, and varicose veins are often dismissed as cosmetic or "normal aging," while they can signal a dangerous progression toward severe...

Read more

New Study: Hospital Affiliation Key Driver of Surging Cost of Outpatient Care

July 24, 2025 4:45 PM

A groundbreaking peer-reviewed study published today in Journal of Market Access & Health Policy reveals that hospital-affiliated physicians across four specialties are far more likely to perform procedures in high-cost hospital outpatient departments than in lower-cost ambulatory surgery centers or medical offices.The study -- "Physician Practice Affiliation Drives Site of Care Cost Differentials: An Opportunity to Reduce Healthcare...

Read more

Clinicians Benchmark Real-World AI Performance in Clinical Workflows: Survey Evaluates Safety, Accuracy, and Automation Readiness

July 24, 2025 12:45 PM

As healthcare AI vendors race to promise autonomy in clinical decision-making and operational workflows, frontline clinicians are increasingly scrutinizing real-world performance. A new flash survey of 155 physician users conducted in July by Black Book Research finds that confidence in AI systems is being built or eroded based on measurable, testable outcomes rather than promotional claims.The survey builds upon recent benchmark studies,...

Read more

Dr. Jennifer Robinson Advocates for Easier Access to Mental Health Care

July 24, 2025 11:15 AM

As mental health challenges continue to rise across the United States, Dr. Jennifer Robinson, founder of Integral Psychiatric and Recovery Services, is urging individuals and communities to take mental health seriously-and to understand that help may be more accessible than they think."I started my online practice to meet people where they are," said Dr. Robinson. "A lot of people want help. They just can't always get to it."Through her work as...

Read more

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025

July 24, 2025 9:00 AM

Utah Medical Products, Inc. [Nasdaq:UTMD] reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent with overall beginning-of-year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and...

Read more

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

July 24, 2025 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in synthetic DNA manufacturing powered by scalable PCR platforms, today announced it received a seventh follow-on order valued at more than $600,000 for a multi-gram quantity of LineaDNA™. The follow-on order was placed by a global manufacturer of in vitro diagnostics (IVDs) under a long-standing supply agreement for the bulk manufacture of LineaDNA used as a...

Read more

SurgiVance Inc. Receives Phase II SBIR to Commercialize Direct-to-Digital Pathology Imaging Technology and Initiates New York State-Funded Clinical Pilot Project

July 24, 2025 9:00 AM

SurgiVance Inc., a startup company in the diagnostic imaging device space with headquarters in New York and Oregon, has been awarded a $2,245,000 National Cancer Institute Small Business Innovation Research Direct-to-Phase II grant (NIH 1R44CA302122).Company Founder Dr. Daniel Gareau said: "The SurgiVance ‘pathology lab-in-a-box' is a novel biospecimen processing platform for direct-to-digital, in-office pathology. Thanks to support from our...

Read more

Empowering Health Through Nutrition: A Conversation With FIMC Executive Director

July 24, 2025 8:35 AM

Addressing the complex health needs of people with chronic conditions requires innovative solutions and strong collaborative efforts. The Food is Medicine Coalition (FIMC) is helping highlight the crucial role nutrition plays in healthcare and is working to provide medically tailored meals and nutrition support to those facing health-related dietary restrictions.Through a grant under the DaVita Giving Foundation, FIMC and DaVita seek to create...

Read more

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors

July 24, 2025 8:02 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective July 22, 2025. The appointments increase the size of the Board from ten to twelve members.Michael Goettler is an accomplished executive with extensive leadership experience in the pharmaceutical industry. Most recently, he served as Chief...

Read more

Tebra Partners With WoundZoom to Simplify Wound Care Management for Independent Practices

July 24, 2025 8:00 AM

Tebra is excited to announce a new partnership with WoundZoom, a leader in integrated wound management solutions. Together, Tebra and WoundZoom deliver an advanced, unified solution tailored to support independent wound care practices, combining advanced wound management technology with simplified workflows to enhance clinical outcomes, improve efficiency, and save valuable time."Our partnership with Tebra enables us to deliver a seamless...

Read more

Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathways in Alzheimer's and Parkinson's

July 24, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a preclinical-stage biotechnology company developing therapies that target the root causes of biological aging and age-related diseases, today announced new preclinical results showing that its lead compound, Telomir-1, restored mitochondrial function without triggering oxidative stress or cell proliferation in human cells derived from a patient with Hutchinson-Gilford Progeria Syndrome...

Read more

DEA Marijuana Rescheduling Judge Mulrooney Retires Amid Constitutional Crisis and MMJ Marijuana Research Lawsuit

July 24, 2025 6:05 AM

The Drug Enforcement Administration's embattled Chief Administrative Law Judge, John J. Mulrooney II, just announced his retirement-leaving behind a legacy not of justice, but of obstruction, secrecy, and constitutional violations.This is the man who presided over the Biden administration's long-delayed cannabis rescheduling proceeding-only to halt it for six months after revelations that the DEA secretly helped anti-reform participants...

Read more

AlzeCure's Rights Issue Oversubscribed, And the Company Resolves on A Directed Share Issue Under the Framework of An Overallotment Option

July 24, 2025 5:20 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB ("AlzeCure" or the "Company"), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced the final outcome of the new share issue with preferential rights for shareholders (the "Rights Issue") that closed on July 22, 2025. The rights issue was subscribed to 212 per cent and thus...

Read more

AlzeCure's Rights Issue Oversubscribed According to Preliminary Results

July 24, 2025 4:20 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB ("AlzeCure" or the "Company"), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced the preliminary outcome of the new share issue with preferential rights for shareholders (the "Rights Issue") that closed on July 22, 2025. Preliminary figures show that approximately 212 per cent of the...

Read more

Genflow Biosciences PLC Announces Clinical Readiness Acceleration

July 24, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to report key preclinical activities in two of its lead programs.GF-1002In preparation for a submission for European Clinical Trial Authorisation (CTA), the EU's regulatory equivalent to the U.S. FDA's IND process, Genflow is continuing to advance key development activities. To support this process, the...

Read more

AlzeCure's Rights Issue Oversubscribed According to Preliminary Results

July 23, 2025 4:15 PM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) ("AlzeCure" or the "Company"), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced the preliminary outcome of the new share issue with preferential rights for shareholders (the "Rights Issue") that closed on July 22, 2025. Preliminary figures show that approximately 212 per cent of the Rights Issue was...

Read more

Champions Oncology Reports Record Annual Revenue of $57 Million

July 23, 2025 4:00 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for the fiscal year and fourth quarter ended April 30, 2025.Fourth Quarter Financial Highlights:Total revenue of $12.3 millionAdjusted EBITDA loss of $1.2 millionNew data licensing revenue of approximately $200,000Operating cash flow of $6.4 millionFiscal Year 2025 Financial Highlights:Record annual revenue of $57...

Read more